featured
Induction Cyclophosphamide With Maintenance Immunosuppression for High-Risk Myasthenia Gravis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile
J. Neurol. Neurosurg. Psychiatr. 2024 Nov 18;95(12)1096-1101, F Chan, TA Hardy, S Malik, S Ramanathan, DS Riminton, SW ReddelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.